UroPharma is a MedTech company focused on global commercialization of innovative and potentially disruptive therapeutic technology to treat a broad range of urinary tract disorders.
UroPharma’s patented drug-delivery device, dtb-instilla™ minimizes the negative side effects of conventional systemic forms of treatment by dispensing the medications directly into the bladder, direct-to-bladder (dtb) therapy.
Company’s Keywords:
urology, spinal injury, incontinence, bladder overactivity, urinary tract infection, direct to bladder, multiple sclerosis, painful bladder, bladder cancer, research, medical device, catheter, development, drug discovery, regulatory compliance, mdr, fda, iso 13485
<9
<
<2012